Results 1-20 of 8,500 for speaker:John Brady
- Public Accounts Committee: Business of Committee (9 Oct 2025)
John Brady: Everyone is very welcome to today's meeting of the Committee of Public Accounts. Before we proceed, I have a few housekeeping matters to go through. Members are reminded of the provisions within Standing Order 226 that the committee shall refrain from enquiring into the merits of policy or policies of the Government or a Minister of the Government or the merits of the objectives of such...
- Public Accounts Committee: Business of Committee (9 Oct 2025)
John Brady: I thank the C and AG. Do members wish to raise any questions or queries on those? No. The first item referred to by the C and AG was the State Laboratory. A draft report was considered by the committee on Vote 14, the State Laboratory, which reports on the excess expenditure reported in the C and AG's report. The sanction of Dáil Éireann is required with respect to the excess...
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: This morning, we will engage with the National Treatment Purchase Fund to discuss its 2024 financial statements, and with Beaumont Hospital to discuss its 2023 financial statements. We are joined by the following representatives from the National Treatment Purchase Fund: Ms Fiona Brady, chief executive officer; Mr. Seán Flood, director of finance; Mr. Eoin Darcy, director of ICT; Ms...
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: I thank Mr. McCarthy. I now invite Ms Brady to give an opening statement on behalf of the NTPF. As set out in the letter of invitation, she has five minutes to make her statement.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: I thank Ms Brady. I now invite Ms Coyle to provide the opening statement on behalf of Beaumont Hospital.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: I thank Ms Coyle. I advise everyone that we will suspend the meeting for about ten to 15 minutes at 12 o'clock. I will now open the floor to members. The lead speaker is Deputy Farrelly, who has 15 minutes. All other members will have ten minutes each. If time permits, there will be a second round of questioning.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: I thank Deputy McAuliffe. I have a few questions. The witnesses are all very welcome. For the record, could Ms Brady repeat the list of hospitals that currently have funding suspended?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: There were three hospitals in total where-----
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Mr. Gloster spoke about insourcing. He made reference to it being a more localised thing to do perhaps ten years ago, but that now the entire health system has become overly dependent on it. Is that something Ms Coyle would like to comment on? Does she think the entire health system is dependent on the NTPF and insourcing? Could Ms Brady please respond?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Could I ask the question of Ms Coyle? Does she think the operation of Beaumont is overly dependent on insourcing?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Prior to the work that has been embarked, was Beaumont overly dependent on insourcing?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: What does the direct impact of the funding being suspended look like for patients who may potentially have been on waiting lists for many years having their cases referred to the NTPF? Do we have numbers in respect of the patients who had were referred in this way? What impact is the suspension of funding having on patients?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: I get all of that. I am just looking for the specific numbers relating to the suspension of funding. How many patients have been referred over to the NTPF? With funding suspended, what is the real impact on patients in the context of their being in a vacuum? Do we have numbers in this regard?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Are their any cases of patients who had been referred to the NTPF and had a date for a procedure or whatever who are now back on an NTPF waiting list?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Were there no cases of direct negative impact on patients?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: That is fair enough. In relation to the cost of insourcing, Ms Brady referred to a split of 70-30. What was the exact figure for insourcing for 2024?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: For the record, what were the figures for insourcing and outsourcing at Beaumont in 2023?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: With regard to SIPO, which one of the members referred to earlier, there is a responsibility on consultants to fill in the relevant statutory declarations. A figure of 25% non-compliance was provided in that regard. There may be reasons for that. Ms Brady gave the example whereby when she was in Drogheda hospital, all consultants filled that in. Is that the case-----